SeraGas SR is a powerful combination of Rabeprazole Sodium (EC), a proton pump inhibitor (PPI), and Domperidone (SR), a prokinetic agent. This formulation provides dual relief from acid-related disorders and gastric motility disturbances by reducing acid secretion and enhancing gastrointestinal peristalsis. It is particularly effective in treating GERD with associated nausea, bloating, and indigestion. Indications: Gastroesophageal reflux disease (GERD) Functional dyspepsia Gastritis and gastric ulcers Nausea and vomiting associated with reflux Bloating and epigastric fullness Non-ulcer dyspepsia Esophagitis Gastroparesis Key Benefits: Dual Mechanism Therapy: • Rabeprazole provides potent acid suppression • Domperidone improves gastric emptying and reduces reflux symptoms Superior Symptom Relief: Controls acidity, heartburn, regurgitation, bloating, and nausea. Extended-Release Advantage: Domperidone (SR) ensures sustained action throughout the day. Improved GI Motility: Enhances stomach and intestinal movement, especially in functional GI disorders. Safe & Well-Tolerated: Minimal CNS side effects with high tolerability profile.